The company generated $103.4 million in revenue and net income of $4.04 million for the first half of 2019.IPO prospectusFor the first half of 2019, Progyny generated $103.4 million in revenue and net income of $4.04 million. That's up from $48.4 million in revenue and $3.3 million in net income in the first six months of 2018.
In the filing, the company says its range of benefits have led to above-average fertility outcomes among members, with in-network IVF pregnancy rates of 60.7%, compared to 52.5% across all IVF clinics. The stock will trade under the symbol "PGNY" on the Nasdaq. The lead underwriters are J.P. Morgan, Goldman Sachs and Bank of America Merrill Lynch.Progyny sells health and technology services to large employers, counting
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Why Trump asked Ukraine's president to look into CrowdStrike, a U.S. cybersecurity company that recently went publicThe company, CrowdStrike is a security software vendor that went public earlier this year. Draining the swamp was an election promise. Democrats and 2016 Crowdstrike
Weiterlesen »
The 8 billion-dollar digital health companies that have triumphed and tanked since going publicWe took a look at 8 digital health companies that were each worth at least $1 billion when they went public. Now, some are worth almost nothing.
Weiterlesen »